BioSpace News Archive

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release second quarter financial results after the close of trading on Tuesday, August 4, 2020.

Align Technology, Inc. (NASDAQ: ALGN) today announced the global launch of the Align Digital and Practice Transformation (ADAPT) service for Invisalign and iTero doctors

Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced today that the company will release financial results for the second quarter 2020, after the market close on Wednesday, July 29, 2020.

BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, further strengthened its balance sheet today as it closed the Company’s previously announced rights offering (the “Offering”)

Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the second quarter ended June 30, 2020 on Wednesday, August 5, 2020, after market close.

GT Biopharma, Inc. announced today it had completed a private offering resulting in aggregate gross proceeds of approximately $5.6 million.

Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its second-quarter 2020 financial results and business highlights. What: Vericel Corporation Second-Quarter 2020 Earnings Call When: Wednesday, August 5, 2020 at 8:30am (EDT) Where: http://investors.vcel.com/events-present

– Industry veteran entrepreneur with 20+ years’ experience founding and financing successful, innovative biotech companies including GenScript and Legend Biotech – – Managing Partner at Kleiner Perkins Caufield & Byers China; Founder of Panacea Venture, funding source for Ziopharm’s joint venture Eden BioCell –

Zelira Therapeutics Ltd ( ASX: ZLD) (OTCQB: ZLDAF ), a global leader in the development of clinically validated cannabis medicines, is pleased to announce it has entered into a binding agreement with US-based

The Hematology/Oncology Pharmacy Association (HOPA) and Horizon CME (HCME) jointly announce their collaboration to provide BCOP accredited education to oncology pharmacists through HCME’s Advanced Practice Provider Oncology Summit (APPOS) series